SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001047469-04-012577
Filing Date
2004-04-20
Accepted
2004-04-20 06:02:56
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 40-F a2134050z40-f.htm 40-F 47855
3 EX-1 a2134050zex-1.htm EX-1 229756
4 EX-2 a2134050zex-2.htm EX-2 212343
5 EX-3 a2134050zex-3.htm EX-3 49204
6 EX-4 a2134050zex-4.htm EX-4 415197
7 EX-5 a2134050zex-5.htm EX-5 2301
8 EX-6.1 a2134050zex-6_1.htm EX-6.1 3609
9 EX-6.2 a2134050zex-6_2.htm EX-6.2 3563
  Complete submission text file 0001047469-04-012577.txt   966019
Mailing Address 3650 WESBROCK MALL V6S 2L2 VANCOUVER BC
Business Address 3650 WESBROOK MALL V6S 2L2 VANCOUVER BC A1 6042225577
CARDIOME PHARMA CORP (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: 40-F | Act: 34 | File No.: 000-29338 | Film No.: 04741639
SIC: 2834 Pharmaceutical Preparations